These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19738063)

  • 1. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis.
    Dopeso H; Mateo-Lozano S; Mazzolini R; Rodrigues P; Lagares-Tena L; Ceron J; Romero J; Esteves M; Landolfi S; Hernández-Losa J; Castaño J; Wilson AJ; Ramon y Cajal S; Mariadason JM; Schwartz S; Arango D
    Cancer Res; 2009 Sep; 69(18):7430-8. PubMed ID: 19738063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
    Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
    Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPHB4 and survival of colorectal cancer patients.
    Davalos V; Dopeso H; Castaño J; Wilson AJ; Vilardell F; Romero-Gimenez J; Espín E; Armengol M; Capella G; Mariadason JM; Aaltonen LA; Schwartz S; Arango D
    Cancer Res; 2006 Sep; 66(18):8943-8. PubMed ID: 16982731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EphB4 expression and biological significance in prostate cancer.
    Xia G; Kumar SR; Masood R; Zhu S; Reddy R; Krasnoperov V; Quinn DI; Henshall SM; Sutherland RL; Pinski JK; Daneshmand S; Buscarini M; Stein JP; Zhong C; Broek D; Roy-Burman P; Gill PS
    Cancer Res; 2005 Jun; 65(11):4623-32. PubMed ID: 15930280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of EphB4 in mesothelioma and its biological significance.
    Xia G; Kumar SR; Masood R; Koss M; Templeman C; Quinn D; Zhu S; Reddy R; Krasnoperov V; Gill PS
    Clin Cancer Res; 2005 Jun; 11(12):4305-15. PubMed ID: 15958611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival.
    Xia G; Kumar SR; Stein JP; Singh J; Krasnoperov V; Zhu S; Hassanieh L; Smith DL; Buscarini M; Broek D; Quinn DI; Weaver FA; Gill PS
    Oncogene; 2006 Feb; 25(5):769-80. PubMed ID: 16205642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.
    Noren NK; Foos G; Hauser CA; Pasquale EB
    Nat Cell Biol; 2006 Aug; 8(8):815-25. PubMed ID: 16862147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
    Yekkala K; Baudino TA
    Mol Cancer Res; 2007 Dec; 5(12):1296-303. PubMed ID: 18171987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stat3 is a negative regulator of intestinal tumor progression in Apc(Min) mice.
    Musteanu M; Blaas L; Mair M; Schlederer M; Bilban M; Tauber S; Esterbauer H; Mueller M; Casanova E; Kenner L; Poli V; Eferl R
    Gastroenterology; 2010 Mar; 138(3):1003-11.e1-5. PubMed ID: 19962983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
    Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
    Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hath1, down-regulated in colon adenocarcinomas, inhibits proliferation and tumorigenesis of colon cancer cells.
    Leow CC; Romero MS; Ross S; Polakis P; Gao WQ
    Cancer Res; 2004 Sep; 64(17):6050-7. PubMed ID: 15342386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC inactivation associates with abnormal mitosis completion and concomitant BUB1B/MAD2L1 up-regulation.
    Abal M; Obrador-Hevia A; Janssen KP; Casadome L; Menendez M; Carpentier S; Barillot E; Wagner M; Ansorge W; Moeslein G; Fsihi H; Bezrookove V; Reventos J; Louvard D; Capella G; Robine S
    Gastroenterology; 2007 Jun; 132(7):2448-58. PubMed ID: 17570218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice.
    Oster H; Leitges M
    Cancer Res; 2006 Jul; 66(14):6955-63. PubMed ID: 16849539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tumor formation and intestinal cell migration by estrogens in the Apc(Min/+) mouse model of colorectal cancer.
    Javid SH; Moran AE; Carothers AM; Redston M; Bertagnolli MM
    Carcinogenesis; 2005 Mar; 26(3):587-95. PubMed ID: 15579483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis.
    Li M; Edamatsu H; Kitazawa R; Kitazawa S; Kataoka T
    Carcinogenesis; 2009 Aug; 30(8):1424-32. PubMed ID: 19458037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland.
    Prosperi JR; Becher KR; Willson TA; Collins MH; Witte DP; Goss KH
    J Cell Physiol; 2009 Aug; 220(2):319-31. PubMed ID: 19326388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiles of intestinal tumors in Apc(Min) mice are unique from those of embryonic intestine and identify novel gene targets dysregulated in human colorectal tumors.
    Reichling T; Goss KH; Carson DJ; Holdcraft RW; Ley-Ebert C; Witte D; Aronow BJ; Groden J
    Cancer Res; 2005 Jan; 65(1):166-76. PubMed ID: 15665292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.